These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Mesenchymal bone marroweaction in hyperergic mesenchymal diseases. II. The clinical significance of mensenchymal bone marrow reactions]. Burkhardt R Klin Wochenschr; 1966 Jan; 44(1):1-12. PubMed ID: 5299265 [No Abstract] [Full Text] [Related]
26. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades. Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487 [TBL] [Abstract][Full Text] [Related]
37. Cutaneous vasculitis and its relationship to systemic disease. Callen JP Dis Mon; 1981 Oct; 28(1):1-48. PubMed ID: 6117435 [No Abstract] [Full Text] [Related]
38. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Sørensen SF; Slot O; Tvede N; Petersen J Ann Rheum Dis; 2000 Jun; 59(6):478-82. PubMed ID: 10834866 [TBL] [Abstract][Full Text] [Related]
39. Giant-cell arteritis--a spectrum of disease. Fenton M Trans Ophthalmol Soc U K (1962); 1969; 88():751-6. PubMed ID: 4394047 [No Abstract] [Full Text] [Related]